申请人:American Cyanamid Company
公开号:US04619941A1
公开(公告)日:1986-10-28
This invention discloses novel N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides which are useful as inhibitors of thromboxane synthetase and/or as antihypertensive agents in the treatment of hypertension and myocardial ischemia.
这项发明揭示了新型的N-[(1H-咪唑-1-基)烷基]-1H-吲哚羧酰胺,可用作血栓素合酶的抑制剂和/或作为抗高血压药物在治疗高血压和心肌缺血中。